Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Drug-induced restless legs syndrome

Остроумова Т. М., Остроумова О. Д., Филиппова Y. А., Парфенов В. А.
Журнал неврологии и психиатрии им. C.C. Корсакова
Т. 120, Вып. 4, С. 129-135
Опубликовано: 2020
Тип ресурса: Обзор

DOI:10.17116/jnevro2020120041129

Аннотация:
Restless legs syndrome (RLS) is a sensorimotor disorder characterized by complaints of a strong desire to move legs during periods of rest or inactivity, which is relieved by movement (most pronounced in the evening or at night). Multiple studies have reported drug-induced RLS caused by antipsychotics, antidepressants and antiepileptic medications. Risk factors for drug-induced RLS include older age, gastrointestinal diseases, high medication dose, simultaneous use of ≥2 drugs. The mechanism of drug-induced RLS is most often associated with the effect of medications on various receptors and neurotransmitter systems, in particular, the dopamine system. Drug-induced RLS treatment includes identification and withdrawal of a drug that caused RLS or a decrease in its dosage. Prevention of drug-induced RLS is based on compliance with the principles of rational pharmacotherapy. © 2020, Media Sphera Publishing Group. All rights reserved.
Ключевые слова:
Adverse drug reactions; Drug-induced restless legs syndrome; Restless legs syndrome
anticonvulsive agent; antidepressant agent; neuroleptic agent; dopamine; dopamine receptor stimulating agent; aged; combination drug therapy; dopaminergic system; drug megadose; drug withdrawal; gastrointestinal disease; human; restless legs syndrome; Review; risk factor; movement (physiology); restless legs syndrome; Aged; Dopamine; Dopamine Agonists; Humans; Movement; Restless Legs Syndrome
Язык текста: Русский
ISSN: 2309-4729
Остроумова Т. М. Татьяна Максимовна 1991-
Остроумова О. Д. Ольга Дмитриевна 1968-
Филиппова Y. А.
Парфенов В. А. Владимир Анатольевич 1957-
Ostroumova T. M. Tat`yana Maksimovna 1991-
Ostroumova O. D. Ol`ga Dmitrievna 1968-
Filippova Y. A.
Parfenov V. A. Vladimir Anatolyevich 1957-
Drug-induced restless legs syndrome
Текст визуальный непосредственный
Журнал неврологии и психиатрии им. C.C. Корсакова
Издательство Медиа Сфера
Т. 120, Вып. 4 С. 129-135
2020
Обзор
Adverse drug reactions Drug-induced restless legs syndrome Restless legs syndrome
anticonvulsive agent antidepressant agent neuroleptic agent dopamine dopamine receptor stimulating agent aged combination drug therapy dopaminergic system drug megadose drug withdrawal gastrointestinal disease human restless legs syndrome Review risk factor movement (physiology) restless legs syndrome Aged Dopamine Dopamine Agonists Humans Movement Restless Legs Syndrome
Restless legs syndrome (RLS) is a sensorimotor disorder characterized by complaints of a strong desire to move legs during periods of rest or inactivity, which is relieved by movement (most pronounced in the evening or at night). Multiple studies have reported drug-induced RLS caused by antipsychotics, antidepressants and antiepileptic medications. Risk factors for drug-induced RLS include older age, gastrointestinal diseases, high medication dose, simultaneous use of ≥2 drugs. The mechanism of drug-induced RLS is most often associated with the effect of medications on various receptors and neurotransmitter systems, in particular, the dopamine system. Drug-induced RLS treatment includes identification and withdrawal of a drug that caused RLS or a decrease in its dosage. Prevention of drug-induced RLS is based on compliance with the principles of rational pharmacotherapy. © 2020, Media Sphera Publishing Group. All rights reserved.